The number of moviegoers in South Korea is expected to plummet by 70 percent this year from 2019 due to restrictions imposed on in-person movie showings and people refraining from going to theaters.
Data from government-affiliated movie promotion committee Korean Film Council shows a sharp decrease from the 230 million who viewed movies at theaters in 2019 to 60 million so far this year.
Box office revenue is expected to plunge this year by the same percentage as the theatergoer numbers.
The dismal number was attributed to restrictions imposed on the number of theater seats and limits placed on late-night showings.
Many South Koreans also avoided spending extended periods confined in theaters.
A major multiplex operator plans to cut the number of its theaters by 30 percent in the next three years.
South Korea's movie industry was expected to catapult to new heights this year after the Oscar win by the movie "Parasite" in February, but the coronavirus pandemic dealt a serious blow as studios pushed back release dates for movie after movie.
It also caused the suspension of the filming of a new movie featuring Song Kang Ho, who played the father of a poor family in Parasite.


OpenAI Tightens AI Safety Monitoring After Security Incidents
REPAY Stock Rises After Visa Platform Connect Collaboration
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows 



